Hilmy N, Basril A, Febrida A
Batan Research Tissue Bank, Center for Research and Development of Isotopes and Radiation Technology, National Nuclear Energy Agency, Jalan Cinere, P.O. Box 7002 JKSKL, Jakarta 12070, Indonesia (e-mail:
Cell Tissue Bank. 2003;4(2-4):185-91. doi: 10.1023/B:CATB.0000007031.38240.8f.
The aim of the work is to find the best solution for statistical sampling technique in validation of radiation sterilization dose (RSD) for biological tissues, according to ISO standard. As a model for sampling are biological tissues retrieved from one cadaver donor which consist of frozen bone grafts (18 packets), lyophilized allografts (68 packets) and demineralized bone powder grafts (40 packets). The size and type of products vary from long bones, cancellous chips to bone powders, tendons and facia lata, that make the number of bioburden per product could not be treated equally. Frozen samples could not be considered as the same production batch with lyophilized samples, because of different processing and irradiation temperature. The minimum number of uniformed samples needed for validation per production batch size, according to ISO 13409, is from 20 to 79 and 20 of them will be used for the test sample size, i.e. 10 for bio-burden determination and the remaining 10 for verification dose. Based on the number of uniformed grafts, statistical sampling can be carried out on lyophilized and demineralized bone grafts, but not on frozen bone grafts. Bioburden determinations were carried out and validated according to ISO 11737-1. Results of average bioburden determination (cfu/per packet), using sample item portion (SIP) = 1, are 5 cfu/packet for lyophilized bone grafts and 4 cfu/packet for demineralized bone powder grafts. Verification doses obtained were 2.40 kGy for lyophilized grafts and 2.24 kGy for demineralized bone powder grafts. The results of verification dose were accepted and the RSD of 25 kGy is substantiated It can be concluded that a statistical sampling technique can be applied if all the grafts produced in the same process such as lyophilized, demineralized as well as frozen are assumed to be in one production batch regardless of sample uniformity such as size, type and weight; for this ISO 13409 can be applied for the validation of RSD.
这项工作的目的是根据ISO标准,找到生物组织辐射灭菌剂量(RSD)验证中统计抽样技术的最佳解决方案。作为抽样模型的是取自一名尸体捐赠者的生物组织,包括冷冻骨移植片(18包)、冻干同种异体移植物(68包)和脱矿骨粉移植物(40包)。产品的尺寸和类型各不相同,从长骨、松质骨碎片到骨粉、肌腱和阔筋膜,这使得每个产品的生物负荷数量无法同等对待。由于加工和辐照温度不同,冷冻样品不能与冻干样品视为同一生产批次。根据ISO 13409,每个生产批次大小验证所需的均匀样品的最小数量为20至79个,其中20个将用于测试样品大小,即10个用于生物负荷测定,其余10个用于验证剂量。基于均匀移植物的数量,可以对冻干和脱矿骨移植物进行统计抽样,但不能对冷冻骨移植物进行统计抽样。根据ISO 11737-1进行生物负荷测定并验证。使用样品项目部分(SIP)=1时,平均生物负荷测定结果(cfu/包)为:冻干骨移植物为5 cfu/包,脱矿骨粉移植物为4 cfu/包。获得的验证剂量为:冻干移植物为2.40 kGy,脱矿骨粉移植物为2.24 kGy。验证剂量结果被接受,25 kGy的RSD得到证实。可以得出结论,如果在同一过程中生产的所有移植物,如冻干、脱矿以及冷冻的移植物,无论样品的均匀性如何,如尺寸、类型和重量,都被假定为在一个生产批次中,则可以应用统计抽样技术;为此,ISO 13409可用于RSD验证。